Table 4 The correlation of TIMP1 expression and clinicopathological characters among 94 stomach adenocarcinoma patients.
From: Sp1 induced gene TIMP1 is related to immune cell infiltration in glioblastoma
Variables | TIMP1 expression | Total | χ2 | p value | |
|---|---|---|---|---|---|
Low | High | ||||
Age (year) | 0.002 | 0.961 | |||
< 70 | 12 | 31 | 43 | ||
≥ 70 | 14 | 37 | 51 | ||
Null | |||||
T stage | 0.816 | 0.366 | |||
T1/T2 | 6 | 9 | 15 | ||
T3/T4 | 19 | 58 | 77 | ||
TNM stage | 4.696 | 0.03 | |||
Ι/II | 14 | 21 | 35 | ||
III/IV | 11 | 46 | 57 | ||
Null | |||||
N stage | 4.546 | 0.033 | |||
N0 | 10 | 12 | 22 | ||
N1/N2/N3 | 16 | 56 | 72 | ||
Null | |||||
Size | 0.213 | 0.645 | |||
≤ 5 cm | 12 | 35 | 47 | ||
> 5 cm | 14 | 33 | 47 | ||
Null | |||||
Sex | 0.396 | 0.529 | |||
Female | 11 | 24 | 35 | ||
Male | 15 | 44 | 59 | ||
Null | |||||
Vessel invasion | 0.044 | 0.835 | |||
No | 17 | 46 | 63 | ||
Yes | 9 | 22 | 31 | ||
Pathologic type | 3.994 | 0.136 | |||
AD | 21 | 43 | 64 | ||
MuA | 3 | 7 | 10 | ||
SRCC | 2 | 18 | 20 | ||
Grade | 0.017 | 0.898 | |||
II | 8 | 20 | 28 | ||
III/IV | 18 | 48 | 66 | ||
CD8 | 0.006 | 0.937 | |||
Negative | 10 | 27 | 37 | ||
Positive | 15 | 39 | 54 | ||
PD1 | 0.247 | 0.619 | |||
Negative | 13 | 30 | 43 | ||
Positive | 12 | 35 | 47 | ||
PDL1 | 0.002 | 0.967 | |||
Negative | 12 | 32 | 44 | ||
Positive | 13 | 34 | 47 | ||
HER2 | 1.196 | 0.274 | |||
Negative | 26 | 62 | 88 | ||
Positive | 0 | 6 | 6 | ||
MLH1 | 1.414 | 0.234 | |||
Negative | 15 | 29 | 44 | ||
Positive | 11 | 37 | 48 | ||
MSH2 | 0.046 | 0.83 | |||
Negative | 15 | 37 | 52 | ||
Positive | 11 | 30 | 41 | ||
MSH6 | 0.36 | 0.549 | |||
Negative | 13 | 28 | 41 | ||
Positive | 13 | 37 | 50 | ||
PMS2 | 0.015 | 0.901 | |||
Negative | 11 | 30 | 41 | ||
Positive | 14 | 36 | 50 | ||
